Dendritic cells (DCs), the most abundant antigen-presenting cells in the lung, have been drawing attention for their roles in specific allergic responses to aeroallergens with support of Th lymphocytes, and in persistent inflammatory changes in allergic asthma. To identify genetic factors that may be involved in the asthma susceptibility and development of the disease phenotypes, we examined association of DC-specific DCNP1 polymorphisms with the disease risk. The case-control study revealed association of the nucleotide variants with serum immunoglobulin E (IgE) levels specific for Dermatophagoides farinae (Der f 1) and Dermatophagoides pteronyssinus (Der p 1), major aeroallergens of dust mites, among subjects with asthma. In particular, the T-allele-carrying genotype frequencies for one of the variants (c.À1289C4T) located in the promoter region were found increased in the asthmatic group with low levels of the mite-specific IgE (odds ratio (OR) ¼ 0.63 (0.48-0.83) for Der p 1). Results from functional analyses indicated that the promoter variant would affect the gene expression by modulating DNA-protein interaction. We propose that the genetic polymorphism of DCNP1 may influence production of specific IgE by altering DC functions in the mite allergen presenting and/or processing. The functional relevance of the genetic variation would provide an important insight into the genetic basis of allergic response to the mite antigens.
Introduction
Asthma is one of the complex-trait diseases caused by interactions between multiple genetic factors and environmental factors, which have a major influence on the onset and severity of the disease.
1,2 Asthma has been recognized as one of the Th2-mediated diseases with a particular profile of cytokine responses. 3 It is, however, evident that other cytokines, classically considered as Th1-specific types, are also associated with the inflammatory responses that characterize chronic asthma. The prevalence of individuals with atopic diseases has increased in recent years, which has become one of the major concerns to the public health. Therefore, identification of the host risk factors for development of asthma and its clinically intermediate phenotypes is important for prevention and intervention of the clinical outcomes of the disease.
Dendritic cells (DCs) are the most important antigenpresenting cells (APCs) in the lung, and have been suggested to be one of the main risk factors for developing asthma based on their roles in the allergic Th2 sensitization. 4, 5 It has previously been reported that DCs can influence polarization of T cells with specific expression and secretion patterns of cytokines, depending on their lineage, maturation status, the pattern of consequent co-stimulatory molecules and the environment in which they reside. [6] [7] [8] [9] One of the DC-specific genes, DC associated nuclear protein 1 (DCNP1: HUGO gene symbol: C5ORF20; OMIM ref.: *609710) drew our attention as a suitable candidate gene for our research. It was initially shown that DCNP1 protein was specifically localized to the nuclear membranes of DCs, and that its transcripts were mainly detected in the mature stage of DCs, indicating that the gene expression is regulated in a differentiation stage-dependent manner. However, the physiological role of the gene still remains to be determined. 10 In addition to its specific expression in DCs, the fact that the DCNP1 gene is located on the human chromosomal region 5q31 prompted us to test the gene. The region on 5q has been identified as susceptibility loci for several inflammatory and autoimmune diseases including bronchial asthma, atopic dermatitis, and Crohn's disease. 11, 12 Among the candidate genes in the 5q31-33 region that have been reported for their linkage with asthma and related phenotypes (IL4, IL13, CD14, SPINK5 13 and ADRB2), the association of IL4 and IL13 loci has been replicated in many studies using diverse ethnic populations (reviewed in reference [14] [15] [16] ).
To explore the possibility that DCNP1 would be a biological and positional candidate gene involved in the development of allergic diseases and asthma, we sequenced the whole gene including 5 0 -and 3 0 -flanking regions, and identified 19 single nucleotide polymorphisms (SNPs) in the Korean population. We genotyped samples from an asthma cohort for five SNPs selected as tagging SNPs. The case-control study revealed that the DCNP1 polymorphisms were associated with serum levels of the dust mite-specific immunoglobulin E (IgE) among the patients with asthma. Based on the functional relevance of one of the variants located in the promoter region to the gene expression, we propose in this report a potential implication of the DCNP1 gene in developing the asthma-related phenotypes in the disease pathogenesis.
Results
We examined the entire DCNP1 gene that includes the exon, the 5 0 -and 3 0 -flanking regions for polymorphic variations in 24 unrelated Korean subjects, and identified 19 SNPs (Figure 1a ) among which eight SNPs were novel in the Korean population (the entire SNPs are listed in Supplementary Table S2 Figure 1a and c). By using the PHASE software to construct haplotypes, we found four common haplotypes (frequency40.10). Based on LDs, minor allele frequencies, and haplotype tagging status, we selected five SNPs for large-scale genotyping and casecontrol association analyses (Figure 1a and c) using samples collected from an asthma cohort. The clinical parameters of (the normal (n ¼ 287) and asthmatic subjects (n ¼ 1044)) are summarized in Table 1 .
In the case-control association study using logistic regression analysis with adjustment for age, sex and smoking status, we found no differences in the distribution of genotype frequencies between the normal and asthmatic groups for any of the SNPs tested, which suggested no association of the DCNP1 polymorphisms with the risk of asthma. There was no difference in genotype frequencies between the non-atopic and atopic populations either (Supplementary Table S1 and S3, respectively). The fact that asthma is usually accompanied with atopic or IgE-mediated inflammation prompted us to investigate the relationship of total or Association of DCNP1 with mite-specific IgE level Y Kim et al specific serum IgE levels with genotype distributions among the subjects. We observed no apparent association with the serum level of total IgE (Supplementary Table  S4 ). However, when examining correlation with specific IgE levels, we found significantly different genotype distributions for several of the SNPs between the subject groups divided with respect to serum IgE levels specific for two of the main aeroallergens of house dust mites, Dermatophagoides pteronyssinus (Der p 1) and Dermatophagoides farinae (Der f 1), in the total population using the asthma status as one of the covariates (Table 2a and b). One of the common SNPs associated with both the allergens was found in the promoter region (c.À1289C4T), and the other in the 3 0 -UTR of the gene (c. þ 1718C4T). The association was found stronger when examined for the Der p 1-specific IgE levels among the asthmatic patients, which revealed two other associated SNPs (c. þ 289G4A and c. þ 2666C4A; Table 2a ). We also observed that Der f 1-specific IgE levels were correlated with the genotype frequencies for c.À1289C4T and c. þ 1718C4T with higher P-values (Table 2b ). The most strongly associated SNP in common for both the antigens was located in the promoter region of the gene. There was higher proportion of the minor allele T carriers for the c.À1289C4T among the asthmatics who had lower levels of the mite-specific IgE than among those who had higher levels of the reagin (odds ratio (OR) ¼ 0.62 (0.47-0.82) for Der p 1, and OR ¼ 0.73 (0.54-0.97) for Der f 1; Table 2a and b). In contrast, the minor allele T-containing genotype frequency for c. þ 1718C4T located in the 3 0 -UTR was found higher in the patients group with increased serum levels of the mite-specific IgE (OR ¼ 1.35-1.42 for Der p 1, and OR ¼ 1.32-1.40 for Der f 1; Table 2a and b). Results from haplotype analyses showing a strong association of the ht2 tagged by c.À1289C4T were also supportive of the possibility that c.À1289C4T be involved in the modulation of the mite-IgE production.
Genomic polymorphisms in promoter regions may lead to modulation of the gene expression. We, therefore, further focused on the association of the DCNP1 promoter variant (c.À1289C4T). Firstly, we examined if the c.À1289C4T association with the mite-IgE levels would be dependent on the atopy status of the patient to other commonly known allergens judged by the skin-prick test (see Materials and methods). To this end, we divided the asthma group (n ¼ 931 excluding 113 subjects with missing clinical data) with respect to the individual's mite allergen-specific IgE levels (Der f 1 or Der p 1-positive vs negative), and atopy status (skin-test positive vs negative), and compared the distribution of genotype frequencies among the subgroups (Table 3) . We observed that the CT and TT genotype frequencies were significantly decreased in the IgE-positive group of the asthmatics compared with the CC genotype (OR ¼ 0.65). We found, however, no difference in the distributions of the genotype frequencies between the skin-test positive and negative subgroups among the IgE-negative patients. This observation further supports the specific association of the DCNP1 promoter variant with serum levels of the dust mite-IgE among the patients.
To further examine potential effects of the DCNP1 promoter variant on the production of mite-specific IgE, we made reporter gene constructs carrying b-lactamasecoding sequences whose expression was governed by the DCNP1 promoter region (Figure 2a ). To determine if the c.À1289C4T variation would indeed exert a regulatory effect on the gene expression, we transiently transfected a murine DC line, XS106 cells (a gift from Dr Akira Takashima from University of Texas Southwestern Medical Center) with the reporter gene constructs containing each allele of the c.À1289C4T. It was shown previously that DCNP1 was highly transcribed in mature DCs 10 and that the XS106 cells displayed stable phenotypes characteristic of mature DCs. 17 As shown in Figure 2b , the cells transiently expressing the C allelecarrying reporter gene showed substantially greater reporter expression than those with T allele-carrying construct. A similar pattern of reporter gene expression was observed using the luciferase reporter gene system (Supplementary Figure S1) , which excluded the possibility of having an indirect effect from the reporter gene itself.
We next investigated the possibility that the c.À1289C4T would alter the gene expression by specifically affecting binding of transcription factors to the SNP-containing region. As shown in Figure 2c , results from gel mobility shift assays using the C or T allelecarrying probe demonstrated the presence of binding activity in the murine DC nuclear extract which formed multiple protein-DNA complexes (lane 2 and 6) as a result of specific interactions with the SNP-carrying sequences (lane 3, 4, 7 and 8). Much stronger DNAprotein interaction was observed with the common C allele-carrying probe than with the minor T allelecarrying probe, which was in accordance with previous reporter gene expression patterns (Figure 2a ). Taken together, our data from the functional analyses suggest that the promoter variant of DCNP1 (c.À1289C4T) may affect the gene expression level in mature DCs by altering DNA-protein interaction in the SNP-containing promoter region of the gene. PC20 was defined by a concentration of methacholine needed to provoke a 20% or greater decrease in FEV 1 . Serum levels of total IgE and specific IgE for Der f 1 or Der p 1 were measured using the CAP system (Pharmacia Diagnostics, Sweden). Individuals who received scores of X1 to the mite allergens were regarded as positives for the specific IgE, and all others were included in the negative category.
Positive group for skin-prick test was defined by the presence of an immediate skin reaction (greater than 3 mm in diameter) to one or more of the tested allergens. *Po0.001 for difference between the normal controls and asthmatic groups.
Association of DCNP1 with mite-specific IgE level Y Kim et al 371 . Logistic regression models were used for calculating odds ratios (95% confidential interval) and corresponding P-values for SNP sites in the total population (All), the subjects with asthma (BA), and the normal control subjects (NC), controlling age, smoking, and sex (and asthma status for the analysis of the total population) as covariates. The common alleles were used as the referent genotype to the heterozygote and homozygote of the minor allele. + denotes the groups with scores of the specific IgE levels 41 and Àwith scores of o1.
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Discussion
Asthma is a typical IgE-mediated disease in which the production of IgE is promoted by the activation of Th2 cells that release a distinct pattern of cytokines such as interleukin 4 (IL4) and IL3 in response to specific antigen presentation. 3, 18 Consistent with these well-established concepts, mite-specific T-cell clones from donors with high serum levels of the specific IgE reportedly produced more IL4 and less interferon-g (IFN-g) than clones from donors with low levels of the IgE. 19 This finding, together with a recent report showing close correlation of IL4 production by T cells with serum concentration of mitespecific IgE, 20 suggests that the patients with hypersensitivity to certain allergens have circulating allergen-specific T cells that have acquired a polarized Th2-specific profile.
Although it has never been directly proved in humans, the DCs are known to play critical roles in shaping the differentiation pathway of naive T cells, which lead to either of Th1 or Th2 subtype as suggested using in vitro system and animal models. [21] [22] [23] [24] [25] This, together with their abundant localization in the lung airways, indicate significant implications of DCs in the development of atopy and allergic airway diseases such as asthma. 26 It was also reported that a treatment of atopic asthma patients with inhaled corticosteroids was able to ameliorate their respiratory capacity and airway hyperresponsiveness in correlation with downregulation of the number of airway DCs. 27 Additionally, an increase in the level of respiratory mucosal DCs that expressed high affinity of IgE receptors has been reported both in allergic rhinitis and asthma conditions. 28 These findings strongly support that DCs have important roles in the pathogenesis and pathophysiology of atopic asthma.
For better understanding the influence of DCs on Th2 sensitization process in asthma, we explored genetic Genotype frequencies are indicated in parentheses. Logistic regression model was used to calculate odds ratio and P-value with adjustments for age, smoking and sex. The skin-prick test-positive group is composed of individuals who have shown hypersensitive reaction to the other tested allergens than the mite antigens. The allergens used for the skin-prick test were described in Materials and methods. (c) Analysis of the allele-specific DNA-protein interaction by using gel mobility shift assays. The filled arrowheads indicate the C or T allele probe-specific complexes. An oligo-nucleotide with TFIID-specific sequence ('NS', non-specific) was used as a negative control for the competitive binding reaction.
Association of DCNP1 with mite-specific IgE level Y Kim et al effects of the DC-specific gene, DCNP1 on the development of the disease-related phenotypes in asthma patients. We report here identification of genetic polymorphisms in DCNP1 among the Koreans, and present statistical and functional evidence for involvement of its promoter variant, c.À1289C4T in the modulation of house dust mite-specific IgE production. Our population-based case-control association study demonstrated strong correlation of the genotype frequencies for c.À1289C4T with serum levels of the IgE for the mite allergens, particularly for Der p 1. In addition to c.À1289C4T, we found three other SNPs: c. þ 289G4A and c. þ 2666C4A in association with the Der p 1-specific IgE level, and c. þ 1718C4T with both the miteIgE levels (Table 2a and b). Since we performed multiple testing for linkage of the five tagging SNPs to asthma and several of the disease-related intermediate phenotypes in the sub-grouped population (no. of comparisons ¼ 135), we attempted to control potential statistical errors by taking into account effects from the multiple comparisons. Although none of the SNPs retain statistical significance when the conservative Bonferroni procedure was applied, the association of the c.À1289C4T with the Der p 1-IgE levels was still significant (corrected P ¼ 0.0473 in the dominant model) when the P-values were adjusted using the false discovery rate (FDR)-controlling Benjamini and Hochberg method. 34 As for the association of the SNPs in the coding region and 3 0 -UTR (c. þ 289G4A, þ 1718C4T and c. þ 2666C4A), considering the loss of their statistical significance with the correction, further replication studies using other cohort samples will be needed to confirm our finding on their implication in the IgE production. In particular, the potential association of the two SNPs, c. þ 1718C4T and c. þ 2666C4A, suggests that they might have influence on the mite-IgE production by affecting the DCNP1 functions. Additional experiments to test for their functional effects, for instance, on the mRNA stability, may be required for validating and substantiating their differential association with hypersensitivity to the mite-specific antigens.
We carried out reporter gene expression and gel mobility shift assays in an effort to assess functional consequences of the c.À1289C4T during the gene activation in the DCs. The data (Figure 2 ) strongly suggested that the nucleotide variant located in the DCNP1 promoter region might affect the overall promoter activity by modulating strength of DNA-protein interaction. Nevertheless, further experiments will be required to substantiate allele-specific binding of the transcription factor in vivo, and to determine its physiological implication in the regulation of the gene expression. We note that our data supporting the functional role for c.À1289C4T were obtained using a murine DC line, which has been widely used by numerous investigators studying DC functions. 17, 29 An ideal way to confirm the allele-differential expression patterns of DCNP1 would be to use the DCs differentiated from blood or bone marrow-derived precursors from human subjects. 10 However, some limiting characteristics of DCs grown in primary culture, such as their sensitivity to even small changes in microenvironmental and culture conditions have been known as inhibitory factors in obtaining statistically significant mean values of expression levels, which would be critical for assessing the DCNP1 expression levels in vivo.
Although the physiological roles are yet to be determined, DCNP1 was previously demonstrated to be mainly expressed in mature DCs. It is known that the mucosal DCs with immature phenotype are capable of allergen uptake and processing, but lack the power to stimulate naive T cells, whereas mature DCs lose their ability to take up antigens but acquire phenotypes of APCs expressing the co-stimulatory molecules and chemokines to attract and activate naive T cells. 30 The case-control study showed that the promoter variant of interest was strongly linked to the specific IgE, but not to total IgE levels (Supplementary Table S4 ), and that the association appears to be independent of the host's atopy status to other allergens. This finding suggests that modulation of the gene expression by c.À1289C4T may affect the DC function as APCs, which initiate immune responses by specifically bringing the mite antigen molecules to T cells through its major histocompatibility complex molecules found on the DC surfaces. In addition, a previous report 10 showing an elevated expression level of DCNP1 in the mature DCs leads us to an idea of c.À1289C4T modulating the DCs maturation as well. Based on the functional association of the minor allele with decreased mite-IgE level, we propose that the c.À1289C4T effect on the specific IgE production would be attributable to subtle changes in DC functions. Functional consequences of this alteration might influence the processing and/or subsequent presentation of the mite antigens to T-cell subsets, which may result in eventual changes in Th1 vs Th2 responses. Nonetheless, it is important to note that the observation of the association found only in the asthmatic group, and not in the normal control group, could imply that the genetic effects of DCNP1 might act not as risk factors, but as modifying factors which modulate host susceptibility to the disease risk factors in the asthma pathogenesis in combination with additional genetic and environmental factors. Possible candidates for those factors may include higher exposure levels of inhaled allergens in the patients, pre-existing Th2 inflammation, or structural injury and/or remodeling in the airways of asthmatics, which eventually lead to phenotypic manifestation of the DCNP1 genetic influences on the mitespecific IgE levels.
In summary, our study demonstrated that genetic variation in the regulatory region of a DC-specific gene, DCNP1 was functionally associated with the mite allergen-specific IgE levels among the Korean asthmatics. We believe that these data further support the DCs roles in discriminating certain allergens and generating allergen-specific Th2 responses. Although mechanisms of association of the 3 0 -UTR SNPs remain to be elucidated, our findings reported here should contribute to better understanding of the implication of DCs in sensitization and inflammatory responses to aero-allergens in the upstream of allergic inflammatory cascade.
Materials and methods
Subjects
Study subjects were recruited at asthma clinics of two affiliated hospitals (Soonchunhyang University Bucheon Hospital and Seoul Hospital) of the Asthma Genome Research Center. The Institutional Review Board of each of the hospitals has approved the study, and an informed consent was obtained from each and every subject before enrollment. All individuals in the case group displayed clinical symptoms consistent with asthma on physical examination. Each patient exhibited airway reversibility, as documented by an inhalant bronchodilator-induced improvement of more than 15% of FEV 1 , and/or an airway hyper-reactivity of less than 10 mg/ml of methacholine. 31 Normal subjects were recruited from spouses of the patients and the general population who had negatively answered to a screening questionnaire for respiratory symptom had FEV 1 greater than 75% predicted, PC 20 of greater than 10 mg/ml and normal findings on a simple chest diagram. Serum levels of total IgE and specific IgE for Der f 1 and Der p 1 were determined by using ImmunoCAP-specific IgE calibrators of the CAP system (samples with less than 0.35 U were given the score of 0 representing undetectable levels of the antibodies, and ones with greater than 0.35 were scored with X1; Pharmacia Diagnostics, Uppsala, Sweden). Atopy status was defined by the presence of an immediate skin reaction (greater than 3 mm in diameter) to one or more of 24 common allergens including those of dust mites (Der f 1 and Der p 1), cat fur, dog fur, cockroaches, grass, tree pollens and ragweed. Clinical parameters of the study subjects were summarized in Table 1 .
Sequencing of the human DCNP1 gene and genotyping To identify SNPs of DCNP1, we sequenced the coding region as well as the 5 0 -flanking region (up to -2.2 kb upstream of the first nucleotide of the ATG codon) and the 3 0 -UTR of the gene using genomic DNA samples collected from 24 unrelated Korean subjects. The ABI PRISM 3700 DNA analyzer (Applied Biosystems Foster City, CA, USA) was used for the sequencing. The primer sequences were designed based on GenBank sequence (Ref. Seq.: NM_130848). The TaqMan assay was employed to genotype the SNPs using genomic DNA samples from the asthma cohort. Detailed information regarding primer and probe sequences for sequencing and genotyping are available at the website (http:// www.snp-genetics.com/user/additional_list.asp).
Statistics
We examined LD between all pairs of biallelic loci with Lewontin's D 0 (|D 0 |), a widely used measure for LD analysis. Haplotypes of each individual were inferred using software, named PHASE based on the algorithm developed by Stephens et al.
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Logistic regression analyses were conducted to examine the differences in the distributions of genotype frequencies among the study subjects with adjustment for age, sex and smoking status as covariates. Correction for the multiple testing was done following Bonferroni procedure and the FDRcontrolling methods of Benjamini and Hochberg 34 and of Hochberg.
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Plasmid construction Genomic sequence of DCNP1 spanning from À2215 to À1 (with respect to A of the ATG codon as þ 1) was amplified by using standard polymerase chain reaction (PCR) methods. DNA samples extracted from C or T allele (c.À1289C4T)-carrying individual were used as templates for the reactions. Sequences of the oligonucleotide primers used for PCR are as follows: 5 0 to 3 0 primer, 5 0 -AGAAAACGAGGGTTGGGACT; 3 0 to 5 0 primer, 5 0 -CTCCTGTGCTTGTGACTGGA. Each PCR product was sequenced before inserting into the upstream of coding region of bla (M) reporter gene (GeneBLAzer, Invitrogen, Carlsbad, CA, USA). Plasmid DNA of the reporter constructs was prepared for transfection using an endotoxin-free DNA preparation kit (Qiagen, Maryland, MD, USA).
Cell culture and transfection XS106, a mouse DC line with the mature-cell phenotypes, and NS47 cells were generously provided by Dr Akira Takashima (University of Texas Southwestern Medical Center). The supernatant from culture media of the NS47 cells was used as supplement for the XS106 cell culture. Cell cultures were conducted as described previously. 33 For transfections, the cells were plated in a black-walled 96-well tissue culture plate with clear bottom (Costar, NY, USA) at a density of 1 Â 10 4 cells/well 24 h before transfection, which was done by using FuGENE 6 reagent (Roche, Indianapolis, IN, USA). Standard amounts of the reporter plasmid DNA employed for each transfection were 200 ng of DNA per well. Cells were incubated in DNA-FuGENE 6 reagent complex containing RPMI-1640 for 48 h before the reporter gene expression assay.
Reporter gene expression assay
We carried out expression assays for the bla (M) gene encoding a modified b-lactamase following the manufacturer's recommendation (GeneBLAzer in vivo detection kit, Invitrogen, Carlsbad, CA, USA). For each sample, the reporter activity was normalized by dividing the measured fluorescence readings by the fluorescence emission signals that represent the number of cells used for each transfection. Relative b-lactamase activity shown in the Figure 2b was determined by dividing the normalized activity of cells transfected by each reporter plasmid by the basal level activity of cells treated with transfection reagent without DNA. Data are representative of six independent experiments. Mean7s.e.m. were indicated. Statistical significance of difference between the two groups was evaluated by using Wilcoxon ranksum test (P ¼ 0.0043).
Gel mobility shift assay
To detect allele-specific DNA-protein complexes, 0.2 pmol of 32 P-end-labeled dsDNA probes were incubated with the XS106 nuclear extract (prepared from 5 Â 10 7 cells using CelLytic NuCLEAR Extraction kit, Sigma-Aldrich Co., St Louis, MO, USA) in a 10-ml reaction mixture containing 10 mM Tris-HCl (pH 7.5), 50 mM NaCl, 1 mM MgCl 2 , 4% (v/v) glycerol, 0.5 mM ethylenediaminetetraacetic acid, 0.5 mM dithiothreitol and 0.05 mg/ml poly(dI-dC) (Promega, Madison, WI, USA). After 30-min incubation at room temperature, the mixture was run on a 4% non-denaturating acrylamide (acryl/bis-acryl ¼ 19:1) gel containing 2.5% (v/v) glycerol in 0.25 Â Tris borate EDTA buffer at 41C to resolve the DNA-protein complexes. Specificity of DNA-protein interaction was tested by incubating the nuclear extract with 100-fold molar excess of unlabeled probe DNA for 10 min before adding the labeled DNA probes. An oligonucleotide DNA with the conserved TFIID-binding sequence was used as a non-specific negative control probe (Figure 2c : 'NS' -5 0 -GCAGAGCATATAAGGT GAGGTAGGA).
